PPARG and Cognitive impairment: To further determine whether the amelioration of HFD-induced cognitive deficits by EPs is independent of modulating gut bacteria-colonocyte interactions, we administered EPs mice with the GW9662, a PPAR-γ antagonist, to inhibit mitochondrial oxidative phosphorylation in colonocytes (EPs-GW) (Figure 6A).